Page last updated: 2024-09-04

barium titanate(iv) and Astrocytoma, Grade IV

barium titanate(iv) has been researched along with Astrocytoma, Grade IV in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cai, R; Guduru, R; Hadjikhani, A; Horstmyer, J; Khizroev, S; Liang, P; Nagesetti, A; Salgueiro, L; Schally, A; Stewart, TS; Stimphil, E1
Almici, E; Battaglini, M; Cappello, V; Cicchi, R; Ciofani, G; de Vito, G; Marchetti, M; Marino, A; Migliorin, S; Pavone, FS; Tapeinos, C1

Other Studies

2 other study(ies) available for barium titanate(iv) and Astrocytoma, Grade IV

ArticleYear
Magnetoelectric nanoparticles for delivery of antitumor peptides into glioblastoma cells by magnetic fields.
    Nanomedicine (London, England), 2018, Volume: 13, Issue:4

    Topics: Antineoplastic Agents; Barium Compounds; Brain; Brain Neoplasms; Cell Line, Tumor; Cell Survival; Cobalt; Drug Carriers; Drug Liberation; Endothelial Cells; Ferric Compounds; Glioblastoma; Growth Hormone; Hormone Antagonists; Humans; Magnetic Fields; Magnetite Nanoparticles; Microvessels; Nanospheres; Particle Size; Peptides; Titanium

2018
Piezoelectric barium titanate nanostimulators for the treatment of glioblastoma multiforme.
    Journal of colloid and interface science, 2019, Mar-07, Volume: 538

    Topics: Antineoplastic Agents, Alkylating; Apoptosis; Barium Compounds; Blood-Brain Barrier; Brain Neoplasms; Cell Proliferation; Drug Screening Assays, Antitumor; Glioblastoma; Humans; Nanoparticles; Nanotechnology; Temozolomide; Titanium; Tumor Cells, Cultured

2019